Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page
- Check6 days agoChange DetectedThe page revision number was updated from v3.6.0 to v3.6.2, indicating a minor maintenance or template update. There are no changes to study details, eligibility criteria, or results content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now states that recruitment is no longer ongoing, clarifying the trial's enrollment status. It also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with a revision tag to v3.6.0.SummaryDifference0.5%

- Check28 days agoChange DetectedThe page now shows a new Revision: v3.5.5, replacing v3.5.4, indicating a small site update without changes to the study details.SummaryDifference0.1%

- Check49 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a new version of the page. This update reflects a metadata/version control change rather than substantive content changes.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s footer software/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” with no associated changes to the underlying study information.SummaryDifference0.1%

- Check77 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.